JP2008528696A5 - - Google Patents

Download PDF

Info

Publication number
JP2008528696A5
JP2008528696A5 JP2007554228A JP2007554228A JP2008528696A5 JP 2008528696 A5 JP2008528696 A5 JP 2008528696A5 JP 2007554228 A JP2007554228 A JP 2007554228A JP 2007554228 A JP2007554228 A JP 2007554228A JP 2008528696 A5 JP2008528696 A5 JP 2008528696A5
Authority
JP
Japan
Prior art keywords
lipid
complex
serine
group
therapeutic agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007554228A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008528696A (ja
Filing date
Publication date
Priority claimed from US11/049,134 external-priority patent/US7351688B2/en
Application filed filed Critical
Publication of JP2008528696A publication Critical patent/JP2008528696A/ja
Publication of JP2008528696A5 publication Critical patent/JP2008528696A5/ja
Pending legal-status Critical Current

Links

JP2007554228A 2005-02-02 2006-02-02 低免疫原性のタンパク質製剤のための組成物および方法 Pending JP2008528696A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/049,134 US7351688B2 (en) 2003-02-05 2005-02-02 Compositions and methods for less immunogenic protein formulations
PCT/US2006/003779 WO2006084095A1 (en) 2005-02-02 2006-02-02 Compositions and methods for less immunogenic protein formulations

Publications (2)

Publication Number Publication Date
JP2008528696A JP2008528696A (ja) 2008-07-31
JP2008528696A5 true JP2008528696A5 (enExample) 2009-04-02

Family

ID=36777576

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007554228A Pending JP2008528696A (ja) 2005-02-02 2006-02-02 低免疫原性のタンパク質製剤のための組成物および方法

Country Status (7)

Country Link
US (1) US7351688B2 (enExample)
EP (1) EP1858532A4 (enExample)
JP (1) JP2008528696A (enExample)
AU (1) AU2006210609A1 (enExample)
CA (1) CA2596280A1 (enExample)
NZ (1) NZ560327A (enExample)
WO (1) WO2006084095A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2007357B1 (en) * 2006-03-30 2016-11-09 The Research Foundation Of State University Of New York Compositions of less immunogenic and long-circulating protein-lipid complexes
EP1988101A1 (en) * 2007-05-04 2008-11-05 Novo Nordisk A/S Improvement of factor VIII polypeptide titers in cell cultures
US10617640B2 (en) 2009-07-07 2020-04-14 The Research Foundation For The State University Of New York Phosphoserine containing compositions for immune tolerance induction
WO2011005850A1 (en) 2009-07-07 2011-01-13 The Research Foundation Of State University Of New York Lipidic compositions for induction of immune tolerance
WO2011016043A2 (en) * 2009-08-06 2011-02-10 Technion Research & Development Foundation Ltd. Antibiotic drug delivery and potentiation
WO2012045769A1 (en) 2010-10-05 2012-04-12 Novo Nordisk Health Care Ag Process for protein production
EP2704688B1 (en) * 2011-05-05 2019-07-10 Matinas BioPharma Nanotechnologies, Inc. Cochleate compositions and methods of making and using same
EP2763659B1 (en) 2011-10-06 2017-07-19 The Research Foundation Of State University Of New York Compositions and methods for immune tolerance induction
JP6783652B2 (ja) 2013-09-24 2020-11-11 ザ リサーチ ファウンデイション フォー ザ ステイト ユニバーシティー オブ ニューヨーク 抗原特異的免疫原性を低減するための組成物及び方法
ES2952038T3 (es) * 2016-04-05 2023-10-26 Univ New York State Res Found Composiciones que contienen fosfoserina para la inducción de la tolerancia inmune

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4127502A (en) * 1977-06-10 1978-11-28 Eastman Kodak Company Stabilizers for reconstituted, lyophilized samples
US4795806A (en) * 1987-07-16 1989-01-03 Miles Laboratories, Inc. Phospholipid affinity purification of Factor VIII:C
US5580856A (en) * 1994-07-15 1996-12-03 Prestrelski; Steven J. Formulation of a reconstituted protein, and method and kit for the production thereof
US6323322B1 (en) * 1997-04-30 2001-11-27 Enzon, Inc. Single-chain antigen-binding proteins capable of glycosylation, production and uses thereof
SE513221C2 (sv) * 1998-04-17 2000-07-31 Net Insight Ab Förfarande och anordning för allokering av tidluckor till en kanal i ett kretskopplat tidsmultiplexerat nät
CA2329768C (en) * 1998-04-27 2008-06-10 Opperbas Holding B.V. Pharmaceutical composition comprising factor viii and neutral liposomes
US20020132982A1 (en) * 2000-11-30 2002-09-19 Balasubramanian Sathyamangalam V. AHF associated dispersion system and method for preparation
ZA200305980B (en) * 2001-02-12 2007-01-31 Res Dev Foundation Modified proteins, designer toxins, and methods of making thereof
WO2003013245A1 (en) * 2001-08-07 2003-02-20 Wisconsin Alumni Research Foundation Polyamines and analogs for protecting cells during cancer chemotherapy and radiotherapy
US20040229793A1 (en) * 2003-02-05 2004-11-18 Balasubramanian Sathyamangalam V. Compositions and methods for less immunogenic protein formulations

Similar Documents

Publication Publication Date Title
JP2015519383A5 (enExample)
JP2004529163A5 (enExample)
KR100381449B1 (ko) 에테르지질리포좀과이들의제약학적용도
JP2015515992A5 (enExample)
Rakotomanga et al. Hexadecylphosphocholine interaction with lipid monolayers
JP2019023243A5 (enExample)
JP2016505545A5 (enExample)
JP6297040B2 (ja) 脳卒中の治療のための神経保護リポソーム組成物および方法
JP2015098498A (ja) 腹腔内投与される脂質ベースの白金化合物製剤を用いた、癌の治療方法
US8252836B2 (en) Preparations of phospholipids and pharmaceuticals containing 5-amino salicylic acid for the treatment of inflammatory bowel disease
ATE469660T1 (de) Gasgefüllte mikrovesikel mit polymer- modifizierten lipiden
CO6260056A2 (es) Composiciones de liposomas para administracion in vivo de compuestos de acido boronico
JP2010532786A5 (enExample)
JP2003530339A (ja) 寄生虫感染症の医療用途のための、ホスホリパーゼa2分解性脂質誘導体を含有する脂質ベースの薬物送達システム
ES2290333T3 (es) Composiciones de vehiculos lipidicos y metodos para la retencion mejorada de farmacos.
WO2003061666A1 (en) Phospholipid bodies and use thereof in the treatment of inflammatory and autoimmune diseases
JP2005505521A5 (enExample)
JP2010507580A5 (enExample)
JP2008526868A (ja) 表面活性剤処置療法
JP2008519064A5 (enExample)
CA2399821A1 (en) Lipid-based drug delivery systems containing phospholipase a2 degradable lipid derivatives and the therapeutic uses thereof
JP2019520407A (ja) 中枢神経系送達のためのコクリエート化抗真菌化合物及びクリプトコッカス感染症の治療
US20120321586A1 (en) Surfactant composition
FI3954360T3 (fi) Hiilihydraattien lääkevalmiste terapeuttiseen käyttöön
JP2008528696A (ja) 低免疫原性のタンパク質製剤のための組成物および方法